Methylphenidate HCl 10mg, 20mg, 30mg, 40mg, 50mg, 60mg; ext-rel caps (contains immediate-release + ext-rel beads); contains sucrose. Not recommended in pediatric patients <6yrs due to a higher plasma ...
LONDON -- Celltech Group PLC said Tuesday its hyperactivity drug Metadate CD showed positive results in a comparative clinical study with Johnson & Johnson's Concerta, the market-leading medication ...
termed "ascending dose," was specifically designed to avoid acute tolerance, which is believed to be the cause of the diminished effectiveness of intermediate-acting methylphenidate preparations ...
LONDON (CNN) -- Celltech received U.S. approval for a drug to treat hyperactive children, boosting profit prospects, the UK's No.1 biotech company has said. The drug Metadate when taken once a day ...
Methylphenidate HCl 10mg, 20mg, 30mg, 40mg, 50mg, 60mg; ext-rel caps (contains immediate-release + ext-rel beads); contains sucrose. High potential for abuse, misuse, and addiction; assess patient’s ...
Find clinical guidance on Metadate CD, including indications, dosing, safety, side effects and evidence-based insights for healthcare professionals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results